![Teva Canada Announces the Launch of <C>ACT Methylphenidate ER® Tablets, a Generic Version of <C>Concerta® for the Treatment of ADHD | Markets Insider Teva Canada Announces the Launch of <C>ACT Methylphenidate ER® Tablets, a Generic Version of <C>Concerta® for the Treatment of ADHD | Markets Insider](https://mma.prnewswire.com/media/657121/Teva_Canada_Limited_Teva_Canada_Announces_the_Launch_of__ACT_M.jpg)
Teva Canada Announces the Launch of <C>ACT Methylphenidate ER® Tablets, a Generic Version of <C>Concerta® for the Treatment of ADHD | Markets Insider
![Methylphenidate extended release chewable tablet Patent Grant Tu , et al. December 8, 2 [Tris Pharma, Inc.] Methylphenidate extended release chewable tablet Patent Grant Tu , et al. December 8, 2 [Tris Pharma, Inc.]](https://uspto.report/patent/grant/10857143/US10857143-20201208-D00001.png)
Methylphenidate extended release chewable tablet Patent Grant Tu , et al. December 8, 2 [Tris Pharma, Inc.]
![These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES ... These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES ...](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-7.jpg&id=587959)